|
Sign In to gain access to subscriptions and/or personal tools.
|
Role of chymase on vascular proliferation
Mizuo Miyazaki
Department of Pharmacology, Osaka Medical College, Takatsuki City, Japan
Shinji Takai
Department of Pharmacology, Osaka Medical College, Takatsuki City, Japan
Key Words: chymase angiotensin II proliferation inhibitor
References
- Hackenthal E., Hackenthal R., Hilgenfeldt U. Isorenin, pseudorenin, cathepsin D and renin. A comparative enzymatic study of angiotensin-forming enzymes. Biochim Biophys Acta 1978; 522: 574-88.[Medline]
[Order article via Infotrieve]
- Reilly CF, Tewksbury DA, Schechter NM, Travis J. Rapid conversion of angiotensin I to angiotensin II by neutrophil and mast cellproteinases. J Biol Chem 1982; 257: 8619-22.[Abstract/Free Full Text]
- Takai S., Shiota N., Kobayashi S., Matsumura E., Miyazaki M. Induction of chymase that forms angiotensin II in the monkey atherosclerotic aorta. FEBS Lett 1997; 412: 86-90.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Takai S., Shiota N., Yamamoto D., Okunishi H., Miyazaki M. Purification and characterization of angiotensin II-generating chymase from hamster cheek pouch. Life Sci 1996; 58: 591-97.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Klickstein LB, Kaempfer CE, Wintroub BU The granulocyte-angiotensin system. Angiotensin I-converting activity of cathepsin G. J Biol Chem 1982; 257: 15042-46.[Abstract/Free Full Text]
- Wintroub BU, Klickstein LB, Dzau VJ, Watt KW Granulocyte-angiotensin system. Identification of angiotensinogen as the plasma protein substrate of leukocyte cathepsin G. Biochemistry 1984; 23: 227-32.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Boucher R., Demassieux S., Garcia R., Genest J. Tonin, angiotensin II system. A review. Circ Res 1977; 41 (4 Suppl. 2): 26-9.[Free Full Text]
- Arakawa K., Maruta H. Ability of kallikrein to generate angiotensin II-like pressor substance and a proposed 'kinin-tensin enzyme system'. Nature 1980; 288: 705-6. 9. Okunishi H., Miyazaki M., Toda N. Evidence for a putatively new angiotensin II-generating enzyme in the vascular wall. J Hypertens 1984; 2: 277-84.[Medline]
[Order article via Infotrieve]
- Okunishi H., Miyazaki M., Okamura T., Toda N. Different distribution of two types of angiotensin II-generating enzymes in the aortic wall. Biochem Biophys Res Commun 1987; 149: 1186-92.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Schwartz LB, Austen KF Structure and function of the chemical mediators of mast cells. Prog Allergy 1984; 34: 271-321.[Web of Science][Medline]
[Order article via Infotrieve]
- Yurt RW, Austen KF Preparative purification of the rat mast cell chymase: characterization and interaction with granule components. J Exp Med 1977; 146:1405-19.[Abstract/Free Full Text]
- Pejler G., Berg L. Regulation of rat mast cell protease I activity: protease inhibition is prevented by heparin proteoglycan. Eur J Biochem 1995; 233: 192-9.[Web of Science][Medline]
[Order article via Infotrieve]
- Takai S., Jin D., Sakaguchi M., Miyazaki M. Chymase-dependent angiotensin II formation in human vascular tissue. Circulation 1999; 100: 654-658.[Abstract/Free Full Text]
- Le Trong H., Parmelee DC, Walsh KA, Neurath H., Woodbury RG Amino acid sequence of rat mast cell protease I (chymase). Biochemistry 1987; 26: 6988-94.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Le Trong H., Neurath H., Woodbury RG Substrate specificity of the chymotrypsin-like protease in secretory granules isolated from rat mast cell. Proc Natl Acad Sci USA 1987; 84: 364-7.[Abstract/Free Full Text]
- Benfey PN, Yin FH, Leder P. Cloning of the mast cell protease, RMCP II. Evidence for cell-specific expression and multi-gene family. J Biol Chem 1987; 262: 5377-84.[Abstract/Free Full Text]
- Caughey GH, Viro NF, Ramachandran J., Lazarus SC, Borson DB, Nadel JA Dog mastocytoma tryptase: affinity purification, characterization, and amino-terminal sequence. Arch Biochem Biophys 1987; 258: 555-63.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Caughey GH, Leidig F., Viro NF, Nadel JA Substance P and vasoactive intestinal peptide degradation by mast cell tryptase and chymase. J Pharmacol Exp Ther 1988; 244: 133-7.[Abstract/Free Full Text]
- Wintroub BU, Schechter NM, Lazarus GS, Kaempfer CE, Schwartz LB Angiotensin I conversion by human and rat chymotryptic protainases. J Invest Dermatol 1984; 83: 336-9.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Urata H., Kinoshita A., Misono K., Bumpus M., Husain A. Identification of highly specific chymase as the major angiotensin II-forming enzyme in the human heart. J Biol Chem 1990; 265: 22348-57.[Abstract/Free Full Text]
- Takai S., Shiota N., Sakaguchi M., Muraguchi H., Matsumura E., Miyazaki M. Characterization of chymase from human vascular tissues. Clin Chim Acta 1997; 265: 13-20.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Takai S., Shiota N., Jin D., Miyazaki M. Functional role of chymase in angiotensin II formation in human vascular tissue. J Cardiovasc Pharmacol1998; 32: 826-33.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Goldstein SM, Kaempfer CE, Proud D., Schwartz LB, Irani A.-MA, Wintroub BU Detection and partial characterization of a human mast cell carboxypeptidase. J Immunol 1987; 139: 2724-29.[Abstract]
- Goldstein SM, Kaempfer CE, Kealey JT, Wintroub BU Human mast cell carboxypeptidase. J Clin Invest 1989; 83: 1630-6.[Web of Science][Medline]
[Order article via Infotrieve]
- Okunishi H., Oka Y., Shiota N., Kawamoto T., Song K., Miyazaki M. Marked species-difference in the vascular angiotensin II-forming pathways: humans versus rodents. Jpn J Pharmacol 1993; 62: 207-10.[Medline]
[Order article via Infotrieve]
- Okunishi H., Kawamoto T., Kurobe Y. et al. Pathogenetic role of vascular angiotensin-converting enzyme in the spontaneously hypertensive rat. Clin Exp Pharmacol Physiol 1991; 18: 649-59.[Web of Science][Medline]
[Order article via Infotrieve]
- Miyazaki M., Okamura T., Toda N. Role of vascular angiotensin-converting system in hypertension. J Hypertens 1988; 6 (Suppl 3): S13-S15.
- Miyazaki M., Okamura T., Okunishi H., Toda N. Vascular angiotensin-converting enzyme in the development of renal hypertension. J Cardiovasc Pharmacol 1986; 8 (Suppl 10): S58-S61.
- Miyazaki M., Okunishi H., Okamura T., Toda N. Elevated vascular angiotensin-converting enzyme in chronic two-kidney, one clip hypertension in the dog. J Hypertens 1987; 5: 155-60.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Jin D., Takai S., Shiota N., Miyazaki M. Roles of vascular angiotensin-converting enzyme and chymase in two-kidney, one clip hypertensive hamsters. J Hypertens 1998; 16: 657-664.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Naftilan AJ, Gilliland G., Eldridge CS, Kraft AS Induction of the proto-oncogene c-jun by angiotensin II. Mol Cell Biol 1990; 10:5536-40.[Abstract/Free Full Text]
- Schelling H., Fischer H., Ganten D. Angiotensin and cell growth: a link to cardiovascular hypertrophy? J Hypertens 1991; 9: 3-15.[Web of Science][Medline]
[Order article via Infotrieve]
- Powell JS, Muller RKM, Rouge M., Kuhn H., Hefti F., Baumgartner HR The proliferative response to vascular injury is suppressed by angiotensin-converting enzyme inhibition. J Cardiovasc Pharmacol 1990; 16: S42-S49.[Web of Science][Medline]
[Order article via Infotrieve]
- Powell JS, Clozel JP, Muler RKM et al. Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury. Science 1991; 245:186-8.[CrossRef]
- MARCATOR Study Group. Does the new angiotensin-converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty? Results of the MARCATOR Study. Circulation 1992; 86: 100-10.[Abstract/Free Full Text]
- Faxon DP Effect of high dose angiotensin-converting enzyme inhibition on restenosis: final results of the MARCATOR Study, a multicenter, double-blind, placebo-controlled trial of cilazapril. The Multicenter American Research Trial With Cilazapril After Angioplasty to Prevent Transluminal Coronary Obstruction and Restenosis (MARCATOR) Study Group. J Am Coll Cardiol 1995; 2: 362-9.
- Miyazaki M., Wada T., Shiota N., Takai S. Effect of an angiotensin II receptor antagonist, candesartan cilexetil, on canine intima hyperplasia after balloon injury. J Hum Hypertens 1999; 13 Suppl 1:S21-S25.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Miyazaki M., Shiota N., Sakonjo H., Takai S. Angiotensin II type 1 receptor antagonist, TCV-116, prevents neointima formation in injured arteries in the dog. Jpn J Pharmacol 1999; 79: 455-460.[CrossRef][Medline]
[Order article via Infotrieve]
- Tamai H., Katoh O., Suzuki S. et al. Impact of tranilast on restenosis after coronary angioplasty: Tranilast Restenosis following Angioplasty Trial (TREAT). Am Heart J 1999; 138: 968-75.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Azuma H., Banno K., Yoshimura T. Pharmacological properties of N-(3',4'dimethoxycinnamoyl) anthranilic acid (N-5'), a new anti-atopic agent. Br J Pharmacol 1976; 58: 483-8.[Web of Science][Medline]
[Order article via Infotrieve]
- Isaji M., Nakajoh M., Naito J. Selective inhibition of collagen accumulation by N-(3,4-dimethoxycinnamoyl) anthranilic acid (N-5') in granulation tissue. Biochem Pharmacol 1987; 36: 469-74.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Jin D., Takai S., Shiota N., Miyazaki M. Tranilast, an anti-allergic drug, possesses antagonistic potency to angiotensin II. Eur J Pharmacol 1998; 361: 199-205.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Hanson R., Powell JS, Dodson T. et al. Effects of angiotensin-converting enzyme inhibition with cilazapril on intimal hyperplasia in injured arteries and vascular grafts in the baboon. Hypertension 1991; 18 (4 Suppl): 1170-76.
- Chandrasekharan UM, Sanker S., Glynias MJ, Karnik SS, Husain A. Angiotensin II-forming activity in a reconstructed ancestral chymase. Science 1996; 271: 502-5. 46. Takai S., Yuda A., Jin D. et al. Inhibition of Chymase Reduces Vascular Proliferation in Dog Grafted Veins. FEBS Lett. (in press).
- McEuen AR, Sharma B., Walls AF Regulation of the activity of human chymase during storage and release from mast cells: the contributions of inorganic cations, pH, heparin and histamine. Biochim Biophys Acta 1995; 1267: 115-21.[Medline]
[Order article via Infotrieve]
- Craig SS, Schwartz LB Human MCTC type of mast cell granule: the uncommon occurrence of discrete scrolls associated with focal absence of chymase. Lab Invest 1990; 63: 581-5.[Web of Science][Medline]
[Order article via Infotrieve]
Journal of Renin-Angiotensin-Aldosterone System, Vol. 1, No. 1,
23-26 (2000)
DOI: 10.3317/jraas.2000.004

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
C. Matsumoto, T. Hayashi, K. Kitada, C. Yamashita, M. Miyamura, T. Mori, A. Ukimura, M. Ohkita, D. Jin, S. Takai, et al.
Chymase Plays an Important Role in Left Ventricular Remodeling Induced by Intermittent Hypoxia in Mice
Hypertension,
July 1, 2009;
54(1):
164 - 171.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. D. Firth, V.-J. Uitto, and E. E. Putnins
Mechanical Induction of an Epithelial Cell Chymase Associated with Wound Edge Migration
J. Biol. Chem.,
December 12, 2008;
283(50):
34983 - 34993.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Kobori, M. Nangaku, L. G. Navar, and A. Nishiyama
The Intrarenal Renin-Angiotensin System: From Physiology to the Pathobiology of Hypertension and Kidney Disease
Pharmacol. Rev.,
September 1, 2007;
59(3):
251 - 287.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Jin, S. Takai, M. Sakaguchi, Y. Okamoto, M. Muramatsu, and M. Miyazaki
An Antiarrhythmic Effect of a Chymase Inhibitor after Myocardial Infarction
J. Pharmacol. Exp. Ther.,
May 1, 2004;
309(2):
490 - 497.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|